China Resources Zizhu Pharmaceutical Co., Ltd.   Report issue

For profit Phase 2 Phase 4
Founded: Beijing China (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
2014
NCT02135835
First Marketed Drug
2011
amlodipine (norvasc)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CHINA RESOURCES | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | China Resources Zizhu Pharmaceutical Co., Ltd.